Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)

Nav

General Info

Geography

Canada (CAN)

United States of America (USA)

Puerto Rico, United States Virgin Islands

Time period covered

01/1994 - 12/2002

Data type

Scientific literature

Keywords

Ischemic heart disease, Ischemic stroke

Citation

Authors

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Journal

JAMA

Volume

288

Issue

Pages

2998–007

Publication year

2002

Suggested citation

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA. 2002; 288(23): 2998–007.

GHDx Entry last modified on: Sep 3, 2019

Header sites

Search form

Main menu

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)

Nav